Among them, the tumor suppressor genes CDKN2A and RB1 are frequently inactivated by copy number deletions or point mutations, whereas the oncogenes CDK4, CDK2, CCND1, and CCNE1 are recurrently amplified in the genomes of some human cancers.1 This evidence concerns the gene CDK4 and cancer.